The effects of combining ionizing radiation and adenoviral p53 therapy in nasopharyngeal carcinoma

International Journal of Radiation Oncology Biology Physics

Volumn 43, Issue 3, 1999, Pages 607-616

  Li, Jian Hua ^a,c   Lax, Stuart A ^a,c   Kim, John ^a,b,c   Klamut, Henry ^a,c   Liu, Fei Fei ^a,b,c  

^a Prncs Margaret Hospital Ontario C   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Adenovirus vector; Apoptosis; Nasopharyngeal carcinoma; p53; Radiation therapy

Indexed keywords

PROTEIN P53; VIRUS VECTOR;

ADENOVIRUS; APOPTOSIS; ARTICLE; CANCER RADIOTHERAPY; CELL CYCLE; CONTROLLED STUDY; GENE TRANSFER; HUMAN; HUMAN CELL; IONIZING RADIATION; NASOPHARYNX CARCINOMA; NONHUMAN; PRIORITY JOURNAL; TREATMENT OUTCOME; VIRUS RECOMBINANT;

ADENOVIRIDAE; BCL-2-ASSOCIATED X PROTEIN; BETA-GALACTOSIDASE; COMBINED MODALITY THERAPY; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DNA FRAGMENTATION; FIBROBLASTS; GENE THERAPY; GENES, P53; GENETIC VECTORS; HUMANS; NASOPHARYNGEAL NEOPLASMS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RADIOTHERAPY DOSAGE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0032972487     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(98)00432-5     Document Type: Article

References (55)

1. Altun M., Fandi A., Dupuis O., et al. Undifferentiated nasopharyngeal cancer (UCNT) Current diagnostic and therapeutic aspects . Int J Radiat Oncol Biol Phys. 32:1995;859-877.
2. Al-Sarraf M., LeBlanc M., Giri P.G.S., et al. Superiority of chemo-radiotherapy (CT-RT) vs radiotherapy (RT) in patients (pts) with locally advanced nasopharyngeal cancer (NPC). Preliminary results of Intergroup (009 9) (SWOG 8892, RTOG 8817, ECOG 2388) randomized study. 1996;ASCO, Philadelphia, PA.
3. Payne D., Liu F.-F., O'Sullivan B., et al. Review of PMH experience with nasopharyngeal carcinoma. 1996;4th International Conference on Head and Neck Cancer, Toronto, Canada.
4. Fries K., Miller W., Raab-Traub N. Epstein-Barr virus latent membrane protein 1 blocks p53-mediated apoptosis through the induction of the A20 gene. J Virol. 70:1996;8653-8659.
5. Pagano J.S. The Epstein-Barr virus and nasopharyngeal carcinoma. Cancer. 74:1994;2397-2398.
6. Szekely L., Selivanova G., Magnusson K.P., et al. EBNA-5, an Epstein-Barr virus-encoded nuclear antigen, binds to the retinoblastoma and p53 proteins. Proc Natl Acad Sci USA. 90:1993;5455-5459.
7. Zhang Q., Gutsch D., Kenney S. Functional and physical interaction between p53 and BZLF1 Implications for Epstein-Barr virus latency . Mol Cell Biol. 14:1994;1929-1938.
8. Bristow R.G., Jang A., Peacock J., et al. Mutant p53 increases radioresistance in rat embryo fibroblasts simultaneously transfected with HPV16-E7 and/or activated H-ras. Oncogene. 9:1994;1527-1536.
9. Clarke A.R., Purdie C., Harrison D., et al. Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature. 362:1993;849-852.
10. Lee J.M., Bernstein A. p53 mutations increase resistance to ionizing radiation. Proc Natl Acad Sci USA. 90:1993;5742-5746.
11. Lowe S.W., Schmitt E.M., Smith S.W., et al. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature. 362:1993;847-849.
12. Siles E., Villalobos M., Valenzuela M., et al. Relationship between p53 status and radiosensitivity in human tumor cell lines. Br J Cancer. 73:1996;581-588.
13. Kastan M., Canman C., Leonard C. p53, cell cycle control and apoptosis Implication for cancer . Cancer Metastasis Rev. 14:1995;3-15.
14. Lee J.M., Abrahamson J., Bernstein A. DNA damage, oncogenesis and the p53 tumor-supressor gene. Mutat Res. 307:1994;573-581.
15. Lu X., Lane D. Differential induction of transcriptionally active p53 following UV or ionizing radiation: Defects in chromosme instability syndromes. Cell. 75:1993;765-778.
16. Fan S., El-Deiry W., Bae I., et al. p53 gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA damaging agents. Cancer Res. 54:1994;5824-5830.
17. Kastan M., Onyekwere O., Sidransky D., et al. Participation of p53 protein in the cellular response to DNA damage. Cancer Res. 51:1991;6304-6311.
18. Kuerbitz S., Plunkett B., Walsh W., et al. Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc Natl Acad Sci USA. 89:1992;7491-7495.
19. Lowe S., Ruley H., Jack T., et al. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell. 74:1993;957-967.
20. Lowe S.W., Bodis S., McClatchey A., et al. p53 status and the efficacy of cancer therapy in vivo. Science. 266:1994;807-810.
21. McIlwrath A., Vasey P., Ross G., et al. Cell cycle arrests and radiosensitivity of human tumor cell lines Dependence on wild-type p53 for radiosensitivity . Cancer Res. 54:1994;3718-3722.
22. Ramqvist T., Magnusson K., Wang Y., et al. Wild-type p53 induces apoptosis in a Burkitt lumphoma (BL) line that carries mutant p53. Oncogene. 8:1993;1495-1500.
23. Show P., Bovey R., Tardy S., et al. Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line. Proc Natl Acad Sci USA. 89:1992;4495-4499.
24. Cirielli C., Riccioni T., Yang C., et al. Adenovirus-mediated gene transfer of wild-type p53 results in melanoma cell apoptosis in vitro and in vivo. Int J Cancer. 63:1995;673-679.
25. Clayman G., El-Naggar A., Roth J., et al. In vivo molecular therapy with p53 adenovirus for microscopic residual head and neck squamous carcinoma. Cancer Res. 55:1995;1-6.
26. Katayose D., Gudas J., Nguyen H., et al. Cytotoxic effects of adenovirus-mediated wild-type p53 protein expression in normal and tumor mammary epithelial cells. Cancer Res. 1:1995;889-897.
27. Liu T.-J., El-Naggar A., McDonnell T., et al. Apoptosis induction mediated by wild-type p53 adenoviral gene transfer in squamous cell carcinoma of the head and neck. Cancer Res. 55:1995;117-3122.
28. Mujoo K., Maneval D.C., Anderson S.C., et al. Adenoviral-mediated p53 tumor suppressor gene therapy of human ovarian carcinoma. Oncogene. 12:1996;1617-1623.
29. Seth P., Brinkmann U., Schwartz G., et al. Adenovirus-mediated gene transfer to human breast tumor cells: An approach for cancer gene therapy and bone marrow purging. Cancer Res. 56:1996;1346-1351.
30. Yang C., Cirielli C., Capogrossi M., et al. Adenovirus-mediated wild-type p53 expression induces apoptosis and suppresses tumorigenesis of prostatic tumor cells. Cancer Res. 55:1995;4120-4213.
31. Zeng M., Cerniglia G.J., Eck S., et al. High-efficiency stable gene transfer of adenovirus into mammalian cells using ionizing radiation. Hum Gene Ther. 8:1997;1025-1032.
32. Zhang W., Fang X., Mazur W., et al. High-efficiency gene transfer and high-level expression of wild-type p53 in human lung cancer cells mediated by recombinant adenovirus. Cancer Gene Ther. 1:1994;5-13.
33. 1 checkpoint and the apoptotic pathway mediated by wild-type p53 sensitizes squamous cell carcinoma of the head and neck to radiotherapy. Arch Otolaryngol Head Neck Surg. 125:1997;507-512.
34. Fujiwara T., Grimm E., Mukhopadhyay T., et al. Induction of chemosensitivity in human lung cancer cells in vivo by Adenovirus-mediated transfer of the wild-type p53 gene. Cancer Res. 54:1994;2287-2291.
35. Gallardo D., Drazan K., McBride W. Adenovirus-based transfer of wild-type p53 gene increases ovarian tumor radiosensitivity. Cancer Res. 56:1996;4891-4893.
36. Gjerset R.A., Turla S.T., Sobol R.E., et al. Use of wild-type p53 to achieve complete treatment sensitization of tumor cells expressing endogenous mutant p53. Mol Carcinog. 14:1995;275-285.
37. Pirollo K., Hao Z., Rait A., et al. p53 mediated sensitization of squamous cell carcinoma of the head and neck to radiotherapy. Oncogene. 14:1997;1735-1746.
38. Spitz F.R., Nguyen D., Skibber J., et al. Adenoviral-mediated wild-type p53 gene expression sensitizes colorectal cancer cells to ionizing radiation. Cancer Res. 2:1996;1665-1671.
39. Li J.-H., Li P., Klamut H., et al. Cytotoxic effects of Ad-p53 expression in two human nasopharyngeal carcinoma cell lines. Cl Cancer Res. 3:1997;507-514.
40. Effert P., McCoy R., Abdel-Hamid M., et al. Alterations of the p53 gene in nasopharyngeal carcinoma. J Virol. 66:1992;3768-3775.
41. Lo K.-W., Mok C.-H., Huang D.P., et al. p53 mutation in human nasopharyngeal carcinomas. Anticancer Res. 12:1992;1957-1964.
42. Sizhong Z., Xiukung G., Zeng Y. Cytogenetic studies on an epithelial cell line derived from poorly differentiated nasopharyngeal carcinoma. Int J Cancer. 31:1983;587-590.
43. Zeng Y. Establishment of an epithelioid cell line and a fusiform cell line from a patient with nasopharyngeal carcinoma. Scientia Sinica. 21:1978;127.
44. Sambrook J., Fritsch E., Maniatis T. 2nd ed. Molecular cloning A laboratory manual . Vol. 3:1989;16-66 Cold Spring Harbor, Cold Spring Harbor.
45. Chou T.-C., Talalay P. Quantitative analysis of dose-effect relationships The combined effects of multiple drugs or enzyme inhibitors . Adv Enzyme Regul. 22:1984;27-55.
46. Hill R.P. Cellular basis of radiotherapy. Tannock I.F., Hill R.P. The basic science of oncology. 1987;259-275 Pergamon Press, New York.
47. Colton T. Statistics in medicine. 1974;Little, Brown and Co, Boston.
48. Steel G.G., Peckham M.J. Exploitable mechanisms in combined radiotherapy-chemotherapy The concept of additivity . Int J Radiat Oncol Biol Phys. 5:1979;85-91.
49. Radford I. p53 status, DNA double-strand break repair proficiency, and radiation response of mouse lymphoid and myeloid cell lines. Int J Radiat Biol. 66:1994;57-560.
50. Linke S., Clarkin K., Wahl G. p53 mediates permanent arrest over multiple cell cycles in response to γ-irradiation. Cancer Res. 57:1997;1171-1179.
51. Clayman G., Trapnell B., Mittereder N., et al. Transduction of normal and malignant oral epithelium by an adenovirus vector: The effect of dose and treatment time on transduction efficiency and tissue penetration. Cancer Gene Ther. 2:1995;105-111.
52. Sun Y., Dong Z., Nakamura K., et al. Dosage-dependent dominance over wild-type p53 of a mutant p53 isolated from nasopharyngeal carcinoma. FASEB J. 7:1993;944-950.
53. Chen X., Ko L., Jayaraman L., et al. p53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells. Gene Develop. 10:1996;2438-2451.
54. Alexander I.E., Russell D.W., Miller A.D. DNA-damaging agents greatly increase the transduction of nondividing cells by adeno-associated virus vectors. J Virol. 68:1994;8282-8287.
55. Alexander I.E., Russell D.W., Spence A.M., et al. Effects of gamma irradiation on the transduction of dividing and nondividing cells in brain and muscle of rats by adeno-associated virus vectors. Hum Gene Ther. 7:1996;841-850.